The 2026 Healthtech Messaging Index
Vellum Health
vellum.health·scored September 1, 2026
12/38
Weak
The signal is faint. Most of this page is about Vellum Health, not the buyer, and AI has little it can repeat. There's a lot of room to move.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for Mobile IV therapy and vascular access services for post-acute and home care settings, it named:
Buyer we put in the prompt: Director of Nursing, VP of Clinical Operations, or Administrator at a skilled nursing facility, home infusion pharmacy, health plan, or acute care hospital. Both the buyer and the category were inferred from Vellum Health’s homepage alone. The model had no web access.
Vellum Health was not on the list.
A buyer who asked AI this question got 8 names and moved on. Vellum Health never came up.
We asked AI who it recommends for "Director of Nursing, VP of Clinical Operations, or Administrator at a skilled nursing facility, home infusion pharmacy, health plan, or acute care hospital" looking for "Mobile IV therapy and vascular access services for post-acute and home care settings". It named Option Care Health, Coram CVS Specialty Infusion Services, BioMatrix Specialty Pharmacy, Accredo Health Group, InfuSystem. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Vellum Health's biggest strength is solution clarity ... a visitor immediately understands they provide 24/7 mobile IV services to post-acute healthcare organizations, reinforced by recognizable partner logos like Encompass Health and Omnicare. The biggest gap is the complete absence of proof: no outcome numbers, no named case studies, no cost-of-inaction framing, and no founder credibility, meaning the page makes claims of clinical excellence and better outcomes it cannot substantiate, leaving sophisticated B2B buyers with no reason to trust or act.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
02Rebellion / Movement
“No named enemy, status quo critique, or industry pattern the company is pushing against anywhere on the page.”
The page is purely descriptive and service-listing; there is no stated rebellion against hospital-centric care, fragmented vascular access, or any named industry problem Vellum is fighting.
All 19 signals, scored 0 to 2.
Total 12/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Expert vascular access, on demand. Vellum Health offers 24/7 mobile IV enablement, treatment, and clinical education.”
The what is clear enough (mobile IV services), but who it's for and the point of view require scrolling ... the hero doesn't immediately signal B2B buyers like payers or SNFs versus individual patients.
- 0
02Rebellion / Movementweakest
“No named enemy, status quo critique, or industry pattern the company is pushing against anywhere on the page.”
The page is purely descriptive and service-listing; there is no stated rebellion against hospital-centric care, fragmented vascular access, or any named industry problem Vellum is fighting.
- 1
03Owned Language & Category
“IV enablement" and "AI-native technology" appear, hinting at a frame.”
"IV enablement" is a mildly distinctive term but is never defined, named as a category, or owned with a framework AI could quote back as uniquely Vellum's.
- 1
04ICP Clarity
“Payers... Skilled Nursing & Long-Term Acute Care... Home Infusion Pharmacies & Providers... Acute Care”
Multiple buyer segments are listed in tabs, which is useful, but no role specificity (e.g., Director of Nursing, VP of Operations) or company size is called out, making it hard for a specific buyer to self-identify instantly.
- 0
05Problem Leadership
“No problem statement anywhere above the fold; page opens with a service menu and then "Expert vascular access, on demand.”
The page leads entirely with the solution and service list, never articulating the buyer's pain ... staffing gaps, hospital transfer costs, delayed IV access ... before presenting Vellum's answer.
- 2
06Solution Clarity
“Vellum Health offers 24/7 mobile IV enablement, treatment, and clinical education.”
A visitor can clearly repeat what Vellum does in one sentence after reading the hero; the service categories reinforce this without ambiguity.
- 0
07Cost of Inaction
“No mention of cost of delays, transfer costs, readmission penalties, or consequences of not acting anywhere on the page.”
The page never names what happens if a buyer does nothing ... no lost revenue, no avoidable hospitalizations, no penalty framing ... so there is zero urgency created.
- 1
08Promised Land
“Now you can deliver the same quality outcomes at home or in any post-acute setting.”
There is a vague after-state implied (care at home, better outcomes), but no specific, vivid promised land ... no concrete picture of what the buyer's world looks like after partnering with Vellum.
Trust Signal
4 signals
- 0
09Proof & Evidence
“No concrete numbers, before/after deltas, percentage improvements, or named outcomes anywhere on the page.”
The page uses adjectives like "Rapid," "High-Quality," and "better outcomes" but provides zero quantified proof to back any claim.
- 1
10Social Proof
“Logos: Omnicare, Encompass Health, PharMerica, Vibra Healthcare, and others shown; one anonymous testimonial: "Director of Nursing, Regional Skilled Nursing Facility”
There are recognizable partner logos and one testimonial, but the testimonial has no name, and there are no case studies, video stories, or outcome-linked quotes with attribution.
- 0
11Authority & Credibility
“No founder credentials, original research, awards, frameworks, books, or published authority signals anywhere on the page.”
Authority is entirely absent ... the page claims clinical excellence but provides no evidence of who is behind Vellum or why they are uniquely credible in vascular access.
- 0
12Alternatives Acknowledged
“No mention of competitors, alternative approaches, or the 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers could use hospital-based vascular access teams, internal staff, or competing mobile services, leaving no trust signal around honest differentiation.
AI Signal
6 signals
- 1
13Customer Focus
“Our IV enablement solutions increase patient convenience and organizational value.”
The page oscillates between customer benefit language and company capability lists; the customer appears as a beneficiary but the company's services remain the protagonist throughout most of the content.
- 1
14AI-Parmesan Index
“AI-powered patient intelligence technology easily integrates with your EMR to reveal new care opportunities.”
AI is mentioned twice but with no mechanistic explanation of how it works, what data it uses, or what specific intelligence it surfaces ... it reads as AI-Parmesan sprinkled on a service business.
- 1
15LLM Quotability
“Move routine, yet costly IV administration out of the hospital and into the home.”
There are a handful of clean declarative sentences, but none are specific or data-backed enough to be citation-ready; an LLM would paraphrase rather than quote them as authoritative.
- 0
16Copyright Freshness
“No visible dates on blog posts, case studies, or press mentions; no copyright year visible in the scraped content.”
There is no recency signal whatsoever ... no dated content, no copyright year, nothing for AI engines to use to assess how current or active this company is.
- 1
17Entity Distinctiveness
“IV enablement" combined with the multi-stakeholder tab model (payers, SNFs, home infusion, acute care) is somewhat distinctive.”
The combination of mobile vascular access plus AI-native technology plus multi-segment targeting gives some distinctiveness, but the description could still plausibly fit a generic mobile health company without the logo.
- 0
18AI Recommendation Check
“AI's picks: Option Care Health, Coram CVS Specialty Infusion Services, BioMatrix Specialty Pharmacy, Accredo Health Group, InfuSystem, National Vascular Care. You were not named.”
We asked AI who it recommends for "Director of Nursing, VP of Clinical Operations, or Administrator at a skilled nursing facility, home infusion pharmacy, health plan, or acute care hospital" looking for "Mobile IV therapy and vascular access services for post-acute and home care settings". It named Option Care Health, Coram CVS Specialty Infusion Services, BioMatrix Specialty Pharmacy, Accredo Health Group, InfuSystem. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“Schedule a Call" CTA at the bottom; "Schedule a procedure" at the top; "Learn More" links mid-page.”
There are multiple CTAs but no numbered process path showing how a buyer goes from interest to engagement, and the primary versus secondary CTA distinction is unclear with competing options scattered across the page.
Your move
Think Vellum Health’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Vellum Health the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.